RADAR
RADAR Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis Pathologie…
PROMESS
PROMESS National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis (PROMESS_1) Pathologie PR Établissement CHU de Brest Promoteur CHU…
JAK-TAP
JAK -TAP JAK Inhibitor Dose TAPering Strategy Study (JAK-TAP) Pathologie PR Établissement CHU de Brest Promoteur CHU de Toulouse Avancement…
DISRUPT
DISRUPT Effect of Controlling Environmental Risk Factors in Established RA (DISRUPT-estRA) Pathologie PR Établissement CHU de Brest Promoteur CHU de…
CRI-RA
CRI-RA Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis Pathologie Polyarthrite rhumatoïde Établissement Brest, Nantes, Orléans, Le Mans, Tours, La Roche…